Kenneth Bate - Insider Trading & Ownership

Entity
Individual
Location
C/O Millennium Pharmaceuticals Inc, 40 Landsdowne Street, Cambridge, MA
Summary
The estimated net worth of Kenneth Bate is at least $541K dollars as of June 27, 2024. Kenneth Bate is the Director of MADRIGAL PHARMACEUTICALS, INC. and owns shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) stock worth about $535K. Kenneth Bate is the Director of AVEO PHARMACEUTICALS, INC. and owns shares of AVEO PHARMACEUTICALS, INC. stock worth about $5.63K.
All Insider Reports
All Insider Reports

Ownership of Kenneth Bate

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MDGL MADRIGAL PHARMACEUTICALS, INC. Director $535K -$8.21M -93.9% Jun 25, 2024
AVEO AVEO PHARMACEUTICALS, INC. Director $5.63K Jan 19, 2023
ATXS Astria Therapeutics, Inc. Director Jun 5, 2024
EPZM Epizyme, Inc. Director Aug 12, 2022
GNCA GENOCEA BIOSCIENCES, INC. Director Jul 1, 2021

Insider Transactions Reported by Kenneth Bate:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.